Characteristics Carotid ultrasound normal N=93 Carotid ultrasound abnormal N=82 p-value
N (%) N (%)
Diabetes (at the time of ultrasound)          
 No 87 (55) 70 (45) 0.171
 Yes 6 (38) 10 (63)  
History of high blood pressure (at the time of ultrasound)          
 No 79 (59) 56 (41) 0.013
 Yes 14 (36) 25 (64)  
Any concurrent statin use (at the time of ultrasound)          
 No 86 (54) 74 (46) 0.599
 Yes 7 (47) 8 (53)  
History of smoking (at the time of ultrasound)          
 No 31 (63) 18 (37) 0.168
 Yes 46 (51) 44 (49)  
History of alcohol consumption (at the time of ultrasound)          
 Never 26 (55) 21 (45) 0.477
 Former 4 (40) 6 (60)  
 Current 44 (60) 29 (40)  
History of renal failure (at the time of ultrasound)          
 No 86 (54) 72 (46) 0.994
 Yes 6 (55) 5 (45)  
BMI measurement (at the time of ultrasound) (kg/m2) 27 (24-29) 26 (24-28) 0.767
Framingham score (at time of ultrasound) 7 (4-8) 8 (5-8) 0.415
CRP value nearest to time of ultrasound (mg/L) 1 (1-3) 2 (1-4) 0.475
Total cholesterol value nearest to time of ultrasound (mmol/L) 5.44 (4.86-6.30) 5.46 (4.94-6.02) 0.530
HDL value nearest to time of ultrasound (mmol/L) 1.09 (0.93-1.37) 1.08 (0.94-1.22) 0.766
LDL value nearest to time of ultrasound  (mmol/L) 3.22 (2.73-4.07) 3.25 (2.80-3.80) 0.815
Triglyceride value nearest to time of ultrasound (mmol/L) 2.13 (1.56-3.56) 2.25 (1.41-3.18) 0.625
apoB value nearest to time of ultrasound (g/L) 1.11 (0.95-1.28) 1.15 (0.97-1.28) 0.439
Glucose value nearest to time of ultrasound (mmol/L) 5.50 (5.10-5.90) 5.70 (5.30-6.00) 0.055
Note: * For continuous variables, we presented the median and the 25th-75th percentiles.
Table 1b: Baseline traditional cardiovascular risk factors of 175 male patients with human immunodeficiency virus